4-[1-[(2R)-2-(6-chloroindol-1-yl)propanoyl]-4-hydroxypiperidin-4-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[(2R)-2-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)propanoyl]piperazin-1-yl]-N-(2-methylpyrimidin-4-yl)benzenesulfonamide;4-[4-[2-(6-fluoroindol-1-yl)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen
C77H93ClF2N16O10S4 — CID 161028315
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[1-[(2R)-2-(6-chloroindol-1-yl)propanoyl]-4-hydroxypiperidin-4-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[(2R)-2-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)propanoyl]piperazin-1-yl]-N-(2-methylpyrimidin-4-yl)benzenesulfonamide;4-[4-[2-(6-fluoroindol-1-yl)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen
4-[1-[(2R)-2-(6-chloroindol-1-yl)propanoyl]-4-hydroxypiperidin-4-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[(2R)-2-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)propanoyl]piperazin-1-yl]-N-(2-methylpyrimidin-4-yl)benzenesulfonamide;4-[4-[2-(6-fluoroindol-1-yl)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen (PubChem CID 161028315) has the molecular formula C77H93ClF2N16O10S4 and a molecular weight of 1604.41 g/mol. Its IUPAC name is 4-[1-[(2R)-2-(6-chloroindol-1-yl)propanoyl]-4-hydroxypiperidin-4-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[(2R)-2-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)propanoyl]piperazin-1-yl]-N-(2-methylpyrimidin-4-yl)benzenesulfonamide;4-[4-[2-(6-fluoroindol-1-yl)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen.
Molecular Properties
| Compound Name | 4-[1-[(2R)-2-(6-chloroindol-1-yl)propanoyl]-4-hydroxypiperidin-4-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[(2R)-2-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)propanoyl]piperazin-1-yl]-N-(2-methylpyrimidin-4-yl)benzenesulfonamide;4-[4-[2-(6-fluoroindol-1-yl)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen |
|---|---|
| PubChem CID | 161028315 |
| Molecular Formula | C77H93ClF2N16O10S4 |
| Molecular Weight | 1604.41 g/mol |
| Exact Mass | 1602.58 |
| IUPAC Name | 4-[1-[(2R)-2-(6-chloroindol-1-yl)propanoyl]-4-hydroxypiperidin-4-yl]-N-(1,3-thiazol-2-yl)benzenesulfonamide;4-[4-[(2R)-2-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)propanoyl]piperazin-1-yl]-N-(2-methylpyrimidin-4-yl)benzenesulfonamide;4-[4-[2-(6-fluoroindol-1-yl)propanoyl]piperazin-1-yl]-N-pyrimidin-4-ylbenzenesulfonamide;molecular hydrogen |
| SMILES | CC(C(=O)N1CCN(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1)n1ccc2ccc(F)cc21.C[C@H](C(=O)N1CCC(O)(c2ccc(S(=O)(=O)Nc3nccs3)cc2)CC1)n1ccc2ccc(Cl)cc21.Cc1nccc(NS(=O)(=O)c2ccc(N3CCN(C(=O)[C@@H](C)N4CCCc5cc(F)ccc54)CC3)cc2)n1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H] |
| InChI | InChI=1S/C27H31FN6O3S.C25H25ClN4O4S2.C25H25FN6O3S.6H2/c1-19(34-13-3-4-21-18-22(28)5-10-25(21)34)27(35)33-16-14-32(15-17-33)23-6-8-24(9-7-23)38(36,37)31-26-11-12-29-20(2)30-26;1-17(30-12-8-18-2-5-20(26)16-22(18)30)23(31)29-13-9-25(32,10-14-29)19-3-6-21(7-4-19)36(33,34)28-24-27-11-15-35-24;1-18(32-11-9-19-2-3-20(26)16-23(19)32)25(33)31-14-12-30(13-15-31)21-4-6-22(7-5-21)36(34,35)29-24-8-10-27-17-28-24;;;;;;/h5-12,18-19H,3-4,13-17H2,1-2H3,(H,29,30,31);2-8,11-12,15-17,32H,9-10,13-14H2,1H3,(H,27,28);2-11,16-18H,12-15H2,1H3,(H,27,28,29);6*1H/t19-;17-;;;;;;;/m11......./s1 |
| InChIKey | TZGXLPZFTFWISM-ISEZAURVSA-N |
| XLogP | 12.60 |
| TPSA | 303.70 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 110 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1604.41 |
| LogP ≤ 5 | 12.60 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161028315 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.